Inventor · disambiguated record
James Nicholas Riggins
Also filed as: RIGGINS JAMES NICHOLAS
19 granted patents·9 pending applications·25 citations·filing 2014–2025
92Inventor score
Files withCODEXIS INC28
Top patents by PatentIndex Score
28 records- 0195US11236311B2T7 RNA polymerase variantsCODEXIS INC·Filed 2020·Granted Feb 1, 2022·3 cites·25 claims
- 0291US10738286B2T7 RNA polymerase variantsCODEXIS INC·Filed 2018·Granted Aug 11, 2020·3 cites·22 claims
- 0391US9822346B2Engineered imine reductases and methods for the reductive amination of ketone and amine compoundsCODEXIS INC·Filed 2014·Granted Nov 21, 2017·6 cites·13 claims
- 0490US11845968B2Engineered deoxyribose-phosphate aldolasesCODEXIS INC·Filed 2022·Granted Dec 19, 2023·1 cites·14 claims
- 0589US10793841B2T7 RNA polymerase variantsCODEXIS INC·Filed 2018·Granted Oct 6, 2020·4 cites·26 claims
- 0689US10407668B2Engineered imine reductases and methods for the reductive amination of ketone and amine compoundsCODEXIS INC·Filed 2017·Granted Sep 10, 2019·2 cites·13 claims
- 0788US2024409916A1Penicillin-g acylasesCODEXIS INC·Filed 2024·Application pending·0 cites
- 0888US2025027061A1T7 rna polymerase variantsCODEXIS INC·Filed 2024·Application pending·0 cites
- 0987US10745681B2Penicillin-G acylasesCODEXIS INC·Filed 2018·Granted Aug 18, 2020·2 cites·4 claims
- 1086US11274286B2Engineered deoxyribose-phosphate aldolasesCODEXIS INC·Filed 2019·Granted Mar 15, 2022·2 cites·5 claims
- 1186US11236312B2T7 RNA polymerase variantsCODEXIS INC·Filed 2020·Granted Feb 1, 2022·1 cites·10 claims
- 1285US12084697B2Penicillin-G acylasesCODEXIS INC·Filed 2023·Granted Sep 10, 2024·0 cites·5 claims
- 1384US12460195B2Engineered deoxyribose-phosphate aldolasesCODEXIS INC·Filed 2023·Granted Nov 4, 2025·0 cites·11 claims
- 1484US10865402B2Penicillin-G acylasesCODEXIS INC·Filed 2020·Granted Dec 15, 2020·1 cites·16 claims
- 1582US2025304924A1Engineered imine reductases and methods for the reductive amination of ketone and amine compoundsCODEXIS INC·Filed 2025·Application pending·0 cites
- 1681US12129494B2T7 RNA polymerase variantsCODEXIS INC·Filed 2021·Granted Oct 29, 2024·0 cites·17 claims
- 1779US2025137019A1Engineered imine reductases and methods for the reductive amination of ketone and amine compoundsCODEXIS INC·Filed 2024·Application pending·0 cites
- 1879US2025129343A1Engineered glucose dehydrogenases and methods for the reductive amination of ketone and amine compoundsCODEXIS INC·Filed 2024·Application pending·0 cites
- 1978US12312609B2Engineered imine reductases and methods for the reductive amination of ketone and amine compoundsCODEXIS INC·Filed 2021·Granted May 27, 2025·0 cites·20 claims
- 2075US11591588B2Penicillin-G acylasesCODEXIS INC·Filed 2020·Granted Feb 28, 2023·0 cites·10 claims
- 2174US11060072B2Engineered imine reductases and methods for the reductive amination of ketone and amine compoundsCODEXIS INC·Filed 2019·Granted Jul 13, 2021·0 cites·7 claims
- 2268US12215368B2Engineered imine reductases and methods for the reductive amination of ketone and amine compoundsCODEXIS INC·Filed 2020·Granted Feb 4, 2025·0 cites·17 claims
- 2368US2022220456A1Transglutaminase variantsCODEXIS INC·Filed 2022·Application pending·0 cites
- 2467US11319531B2Transglutaminase variantsCODEXIS INC·Filed 2018·Granted May 3, 2022·0 cites·8 claims
- 2566US12215359B2Engineered glucose dehydrogenases and methods for the reductive amination of ketone and amine compoundsCODEXIS INC·Filed 2020·Granted Feb 4, 2025·0 cites·21 claims
- 2662US2024190926A1P450-bm3 variants with improved activityCODEXIS INC·Filed 2023·Application pending·0 cites
- 2756US2023159904A1Carboxyesterase polypeptides for kinetic resolutionCODEXIS INC·Filed 2021·Application pending·0 cites
- 2850US2021269789A1Engineered branched chain ketoacid decarboxylasesCODEXIS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Nicholas Riggins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →